Primary systemic amyloidosis and the gastrointestinal tract. by Fogarty, D. G. & McFarland, R. J.
The UlsterMedicalJournal, Volume 64, No. 2, pp. 191 - 196, October 1995.
Case Report
Primary systemic amyloidosis and the
gastrointestinal tract
D G Fogarty, R J McFarland
Accepted I September 1995
Clinical manifestations of primary amyloidosis can be subtle, particularly when the
gastrointestinal tract is involved. We present two cases that illustrate thediversity ofsuch
involvement and the subsequent problems with diagnosis. Gastrointestinal effects of
primary systemic amyloidosis are reviewed and clinical pointers towards diagnosis are
discussed. In particular these cases illustrate the importance ofproviding all the clinical
details to the pathologist and mentioning amyloidosis as a possible diagnosis.
CASE 1
A 47-year-old lady presented to surgical outpatients with a three month history of
diarrhoea, mild steatorrhoea, central abdominal discomfort and 4 kg weight loss. She
complained of nausea and fatty food intolerance over the preceding two years: oral
cholecystogram at another hospital had revealed a solitary large gallstone. Routine
biochemical andhaematological tests were normal. Three day faecal fats were elevated at
76.1 mmol/l (normal<I8mmol/1). Barium meal, follow through and barium enema were
normal. Antigliadin antibody, auto-antibody screen and a gut hormone profile were
normal. Incidental proteinuria was documented and later measured at 1 g/24 hrs. She
underwentcholecystectomy whichimprovedsomesymptoms,butsteatorrhoeaandweight
loss persisted. A further small bowel series showed a coarse mucosal pattern in keeping
with malabsorption. Jejunal biopsy was normal as was endoscopic retrograde cholecysto-
pancreatography. Colonoscopy was performed to exclude colitis and biopsies were
initially reported as normal.
Ayearlaterthepatientcomplainedofeasybruising,andareasofpurpuraandhepatomegaly
were found on examination. Mild elevation ofalkaline phosphatase and gamma glutamyl
transferase were noted. The prothrombin time was prolonged and a mild normocytic,
normochromic anaemia had developed. Ultrasound and isotope liver scans suggested
metastatic disease in the liver. At laparotomy the liverand spleen were enlarged andfirm
andpale in appearance. A livernodule wasbiopsied andCongo red stainingdemonstrated
amyloid fibril deposition. The fibril type was not identified. No evidence ofmalignancy
was seen. Restaining ofthecolonicbiopsiespreviouslyreportedasnormal showedsimilar
amyloiddeposition. Electrophoresis ofplasmaand urineproteins wererepeatedly normal
and a bone marrow biopsy was normal with 4% plasma cells.
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Over the following year she developed cardiac failure and postural hypotension. An ECG
showed small voltage complexes with a pseudoinfarction picture of septal Q waves. She
subsequently developed vertebral collapse with isotope bone scan evidence of bony
infiltration. She died in hospital three and a half years after presentation due to the
combined effects of heart failure and cachexia.
CASE 2
A 57-year-old lady presented to the gastroenterology clinic with a two year history of
crampy lower abdominal pain and a two month history of profuse watery diarrhoea. She
described episodes of nocturnal diarrhoea and faecal incontinence but no blood loss. She
had lost 4 kg in weight. A recent barium enema had been normal. Six years previously she
had been diagnosed as having a cutaneous vasculitis, having presented with a diffuse
bruising purpuric rash. Skin biopsy at that time demonstrated thickened dermal blood
vessels with C Iq deposition. There were no serological markers or other features of
vasculitis. A yearpriorto this presentation, investigation foratrial fibrillation had revealed
mild cardiomegaly, and echocardiographic evidence ofearly left ventricular hypertrophy.
On examination there was a purpuric rash over her upper chest, arms and peri-orbital area
(figure 1a, b, c). Dipstick urinalysis showed proteinuria. Blood pressure was 90/60 mmHg.
Flexible sigmoidoscopyrevealedadiffuselyabnormal mucosawithaglisteningoedematous
appearance.Therewerefriableareaswhichbledeasilyoncontact. Clinically herpresentation
was consistent with colitis, possibly vasculitic in origin. Rectal biopsy however showed
onlythickwalledsubmucosal vessels. Fullbloodcount,sedimentation rate, andbiochemical
investigations remained normal throughout. A small bowel series showed rapid transit but
no mucosal abnormality. A therapeutic trial of prednisolone enemas and oral mesalazine
produced noclinical benefit. She was laterreadmitted forfurtherinvestigation ofpersisting
Fig 1(1. Face.
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Fig lb. Wrist
Fig Ic. Upper chest
© The Ulster Medical Society, 1995.The Ulster Medical Journal
diarrhoea and an episode of rectal bleeding. Repeat sigmoidoscopy showed the same
mucosal appearance and further biopsies were taken though this time the possibility of
amyloidosis was raised.
Light microscopy with Congo red staining revealedamyloiddepdsition in the submucosa,
vessel walls and interstitium. There were no features ofvasculitis or inflammatory bowel
disease. Stainingfor AA amyloid fibrils wasnegativeandthepathologistfeltthisprobably
represented AL amyloidosis. Congored staining ofthe archival samples from skin andthe
recent rectal biopsy showed similar amyloid deposition. Plasma protein and urine
electrophoresis which had been previously normal both now showed a small discrete IgA
kappa light chain. Bone marrow aspirate and trephine showed a normal plasma cell
population. Just prior to this admission she had presented elsewhere with an episode of
atrial fibrillationandcongestivecardiacfailure.Anechocardiogramshowedleftventricular
hypertrophy with a ground glass appearance typical ofamyloiddeposition. Impairmentof
ventricularfunction wasnoted. The patient was treatedwith anACEinhibitor, digoxinand
symptomatic anti-diarrhoealtherapy. Two yearsafterdiagnosisshediedfollowing abowel
perforation and peritonitis. Post-mortemrevealed no evidenceofmyeloma orother source
of amyloid.
DISCUSSION
The term amyloid, meaning "starchlike", refers to the first descriptions of its staining
pattern with iodine in the 19th century (reviewed in ref. 1). Amyloidosis encompasses a
group of diseases characterised by deposition of a fibrillar, proteinaceous material in
various tissues. Pathological diagnosis today is still basedlargely onCongo red stainingof
the amyloid fibril subunit when the typical apple-green birefringence is seen under
polarisedlight.' Classificationofamyloidosisisnowbasedonthebiochemicalcharacteristics
of these protein fibrils.2 At least fifteen normally non-fibrillary proteins have been
identified as precursors of the pathogenic amyloid fibril. Despite differences in primary
fibril structure the organisation ofthe fibrils into similar secondary structures with a beta-
pleated sheet conformation probably favours deposition and appears to be acrucial step in
amyloidogenesis. Congo-red staining canoccasionally be absent and in such cases typical
amyloid fibrillar change has been recognised by electron microscopy.3 The amyloid-protein
associated with plasmacell dyscrasias (AL- amyloidprotein fromlightchain ) is the same
protein found inprimary amyloidosis. Thisreflects a commonpathogenesisbetweenthese
plasmacellproliferativeprocesses, andtheseparationofALamyloidosis intopatientswith
and without multiple myeloma is by no means clear cut.3
Using sensitive techniques a paraprotein band may be detected in serum or urine in 86%
ofpatients with primary amyloidosis.i When no monoclonal protein is demonstrated the
possibility ofunrecognised familial amyloid polyneuropathy should be considered.4
In primary amyloidosis initial findings associated with multiple myeloma such as lytic
bone lesions, hypercalcaemia and renal failure are usually absent. Clinical manifestations
of the extracellular deposition of these relatively insoluble protein fibrils depend on the
extent ofamyloid deposition and the organ involved.
The clinical expression ofamyloidosis in the gastrointestinal tract depends on the site of
GI involvement and may be less obvious than cardiac, neural or renal involvement.
In a large series of patients with primary amyloidosis 8% of 769 patients had clinical
gastrointestinal involvement.' However diagnosis ofprimary systemic amyloidosis is by
rectal biopsy, where 80% are positive. This suggests either asymptomatic deposition or
poor clinical recognition of the effects on the GI tract.
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Any partofthegastrointestinal tractmaybeinvolvedandcancausearangeoffeaturesfrom
obstruction, malabsorption, ulceration, haemorrhage, infarction to more non-specific
features such asdiarrhoeaandconstipation.Weightloss as seen inboth caseshereisalmost
universal. Given the range ofclinical expression the clue to diagnosis lies in the duration
of symptoms and the associated features ofamyloid in other organs.
Case 1 illustrates malabsorption as a presenting feature. Malabsorption may be due to
mucosal infiltration or autonomic neuropathy with bacterial overgrowth. Pancreatic
involvementhasbeendescribedand may accountforthesignificantfatmalabsorption seen
in this case.6The diagnosis ofprimaryamyloidosis was notmadeuntilhepatic involvement
occurred eighteen months after presentation. Clues to hepatic amyloidosis include
hepatomegaly out ofproportion to theupset in liverfunction tests andHowell-Jollybodies
due to hyposplenism.3 In such patients associated proteinuria and a monoclonal protein
band can help withdiagnosis. Inthis case the normal serumandurineelectrophoresis raise
the possibility ofasporadic formoffamilialamyloidosis. Howeverhepatic diseasecausing
hepatomegaly or cholestatic liver function tests occurs in 16% of patients with primary
amyloidosis andrarely inpatients withfamilialamyloidosis.4This featureplus the absence
ofperipheral neuropathy was nottypicaloffamilialamyloidosis. Itisalsolikelythatasmall
monoclonal protein band was not demonstrated during standard plasma and urine
electrophoresis. Screening ofserum and urine forthe monoclonal proteinpeakisbestdone
afterdirectcommunicationwiththebiochemistrylaboratory, whereimmunoelectrophoresis
may be more sensitive. This patient later had evidence ofcardiac and autonomic disease.
Bony involvement with vertebral collapse has been described before in association with
amyloidosis without overt myeloma.7
Case 2 demonstrates colonic amyloidosis with preceding skin and cardiac involvement.
Amyloid deposition in the colon, although common on biopsy, is rarely clinically
significantorradiologicallyobvious. CTscanning candemonstratebowel wallthickening.8
The cardiac and skin involvement were felt to be unrelated to her diarrhoea until after
diagnosis. Leftventricularhypertrophy withouthypertensionorfeaturesofcardiomyopathy
is another clue to diagnosis. This aspect ofthe disease is seen more commonly now with
the advent of echocardiography. ECG changes such as the pseudoinfarction pattern seen
in the first patient occur later. Cardiac failure is a poor prognostic feature in primary
amyloidosis with a median survival ofeight months.3
Both patients had early evidence of renal involvement with persistent proteinuria. This
clinical clue was disregarded until after diagnosis. Nephrotic syndrome, seen in 44% of
patients, is the commonestmodeofpresentation.3 Progressive renaldiseaseis seenusually
inthepresenceofaraisedcreatinine ornephroticrangeproteinuria atpresentation,dialysis
being required for 18% of a large series of patients with primary amyloidosis.9
Neitherpatient had macroglossia which occurs in only 10% ofpatients. Both patients had
evidence ofautonomic neuropathy withpostural hypotensionbut nofeatures ofperipheral
neuropathy. Both patients demonstrated skin involvement, the second patient having
presented six years previously with the typical purpuric rash and capillary fragility. This
is a classical example of cutaneous involvement by amyloidosis though only 5-16% of
patients have purpura at presentation. The non-specific findings on skin biopsy were
erroneously interpreted as vasculitis for which she was treated with immunosuppressive
agents for a number of months. Immunosuppression has been tried unsuccessfully in
primary amyloidosis and nowchemotherapy with melphalan andprednisolone isreserved
for some patients where response rates ofonly 20% are seen.'0 These patients who have
less advanced disease show a median survival of6-7 years.
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These cases illustrate the subtlety of primary amyloidosis affecting the gastrointestinal
tract. Earlier diagnosis can be achieved using the extragastrointestinal clues mentioned
aboveinassociation withurineandplasmaelectrophoresis. Evenatthis stagethediagnosis
can be missed ifthe pathologist is notalerted to the possibility ofamyloidosis as aclinical
differentialdiagnosis.Thisapproachwillavoidunnecessaryinvestigationandsubsequently
inappropriate and potentially dangerous treatment.
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